Gu, Wei
- Columbia University · Pathology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #4,577
- Sustained Excellence
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pathology
NIH Funding · FY2023
Linked Award Amount
$1.8M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#4,577
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Gu, Wei as a PI. Multi-PI records show the full award amount for context.
- 5R35CA253059-03R35Contact PIp53-mediated metabolic regulation in tumor suppressionColumbia University · Pathology (NIH department code)$952.6Kaward amount
- 5R01CA258390-02R01Contact PICo-regulation of p53 and PD-L1 by the VPRBP-USP2 axis in transcription and ubiquitylationColumbia University · Pathology (NIH department code)$459Kaward amount
- 5R01CA254970-03R01Contact PINovel small molecule USP7 Inhibitors for p53 activation and cancer therapyColumbia University · Pathology (NIH department code)$363.2Kaward amount
Award organization
Organizations that administered FY2023 awards listing Gu, Wei as a PI.
FY2023 award administered by Columbia University (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardColumbia University
- 2006$500K Cumulative Funding
- 2006Entered Top 50% NationallyRanked #6704
- 2007$1M Cumulative Funding
- 2008$2M Cumulative Funding
- 2009Entered Top 25% NationallyRanked #4926
- 2010$5M Cumulative Funding
- 2012R01 Grant Holder
- 2013$10M Cumulative Funding
- 2020Entered Top 10% NationallyRanked #1506
- 2022$25M Cumulative Funding